CSIMarket


Alexion Pharmaceuticals Inc   (ALXN)
Other Ticker:  
 


 

Alexion Pharmaceuticals Inc

ALXN's Financial Statements and Analysis



Alexion Pharmaceuticals Inc reported in I. Quarter net earnings per share of $2.50 a decrease by -4.21 % year on year from $2.61 and decline of -37.5 % from $4.00 earned in IV. Quarter (Dec 31 2019).


I. Quarter
Earnings Per Share Revenues
$ 2.5 $  1,445 Mill
$-0.11     -4.21 % $+304M     +26.69 %



Alexion Pharmaceuticals Inc 's Revenue rose by 26.69 % in I. Quarter (Mar 31 2020) year on year, to $1,445 million and advanced by 4.37 % sequentially.


Alexion Pharmaceuticals Inc is Expected to report next financial results on July 23, 2020.

More on ALXN's Income Statement



Alexion Pharmaceuticals Inc 's net income of $558 million in I. Quarter decreased by -5.15 % from net earnings of $588 million achieved in I. Quarter a year ago.

Sequentially net earnings fell by -37.28 % from net income of $889.00 million realized in previous quarter.

More on ALXN's Growth

Inventories grew by 21.69 % to $587 million from I. Quarter a year ago, sequentially inventories fell by -6.5 %. In I. Quarter company's net cash and cash equivalents decreased by $-368 million, capital expenditures grew by -72.27%, to $-12 millions compare to same quarter a year ago and rose by -59.33% from IV. Quarter (Dec 31 2019).

More on ALXN's Cash flow Statement


Alexion Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals Inc earned $ 9.90 cash per share, on a free-cash flow basis 93.26 % of net earning per share.

Book value grew by 4.69 % sequentially to $52.78 per share, 91.63% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value fell to $ 11.18 per share from $ 12.93.

Company repurchased 1.00 million shares or 0.45 % in I. Quarter.
Interest Coverage Ratio was 28.49. Debt Coverage Ratio was 0.95.

More on ALXN's Dividends

 Market Capitalization (Millions) 25,911
 Shares Outstanding (Millions) 223
 Total Debt (Millions $) 2,470
 Revenue (TTM) (Millions $) 5,296
 Net Income (TTM) (Millions $) 2,374
 Cash Flow (TTM) (Millions $) 989
 Capital Exp. (TTM) (Millions $) -139
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273




Alexion Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals Inc earned $ 9.90 cash per share, on a free-cash flow basis 93.26 % of net earning per share.

Book value grew by 4.69 % sequentially to $52.78 per share, 91.63% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value fell to $ 11.18 per share from $ 12.93.

Company repurchased 1.00 million shares or 0.45 % in I. Quarter.
Interest Coverage Ratio was 28.49. Debt Coverage Ratio was 0.95.

More on ALXN's Balance Sheets

 Market Capitalization (Millions) 25,911
 Shares Outstanding (Millions) 223
 Total Debt (Millions $) 2,470
 Revenue (TTM) (Millions $) 5,296
 Net Income (TTM) (Millions $) 2,374
 Cash Flow (TTM) (Millions $) 989
 Capital Exp. (TTM) (Millions $) -139
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273


   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MCK's Profile

Stock Price

MCK's Financials

Business Description

Fundamentals

Charts & Quotes

MCK's News

Suppliers

MCK's Competitors

Customers & Markets

Economic Indicators

MCK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright Š 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071